Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

COVID-19 & Psychiatry: A Retrospective Chart Review

Active, not recruiting

Conditions: COVID-19

Interventions: Other: No intervention

First Posted Date: 2022-02-17

Last Posted Date: 2024-04-05

Lead Sponsor: Northwestern University

Target Recruit Count: 65000

Registration Number: NCT05244096

Locations: 🇺🇸
Northwester Clinical Research Program, Chicago, Illinois, United States

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Phase 1

Recruiting

Conditions: Glioblastoma
Recurrent Glioblastoma
Astrocytoma
Glioblastoma, IDH-Wildtype
MGMT-Unmethylated Glioblastoma

Interventions: Drug: Mycophenolate Mofetil
Other: Quality-of-Life Assessment
Radiation: Radiation Therapy
Drug: Temozolomide

First Posted Date: 2022-02-11

Last Posted Date: 2025-05-16

Lead Sponsor: Northwestern University

Target Recruit Count: 60

Registration Number: NCT05236036

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Investigational MRI Clinical Software and Hardware

Phase 4

Recruiting

Conditions: Image, Body

Interventions: Radiation: MRI
Drug: Gadavist 2Ml Solution for Injection

First Posted Date: 2022-01-31

Last Posted Date: 2024-12-16

Lead Sponsor: Northwestern University

Target Recruit Count: 2000

Registration Number: NCT05215132

Locations: 🇺🇸
Northwestern University- Feinberg School of Medicine, Chicago, Illinois, United States

ED Physical Therapy for Chronic Low Back Pain

Not Applicable

Active, not recruiting

Conditions: Low Back Pain

Interventions: Other: ED Physical Therapy

First Posted Date: 2022-01-25

Last Posted Date: 2025-02-19

Lead Sponsor: Northwestern University

Target Recruit Count: 128

Registration Number: NCT05206630

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Adaptations of the Brain in Chronic Pain With Opioid Exposure I

Active, not recruiting

Conditions: Opioid Use
Chronic Back Pain

First Posted Date: 2022-01-24

Last Posted Date: 2024-03-19

Lead Sponsor: Northwestern University

Target Recruit Count: 250

Registration Number: NCT05203770

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Shirley Ryan Ability Lab, Chicago, Illinois, United States

Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma

Phase 2

Active, not recruiting

Conditions: Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation
Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
Large B-Cell Lymphoma With IRF4 Rearrangement
Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
Recurrent Intravascular Large B-Cell Lymphoma
Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Refractory Transformed B-Cell Non-Hodgkin Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified